Janus Henderson Horizon Biotechnology Fund H2 USD
ISIN LU1897414485 / Valor 44961728
Janus Henderson Horizon Biotechnology Fund H2 USD
UMushroom community rating:
Janus Henderson Horizon Biotechnology is focused on long-term capital growth by investing predominantly in the equity and equity-related securities of biotechnology and biotechnology-related companies around the world. Managed actively by Andy Acker and Daniel Lyons, the fund aims to outperform the NASDAQ Biotechnology Total Return Index by two percent annually over any five-year period. To achieve its goals, the fund allocates at least 80% of its assets to these biotech-focused equities and may use derivatives to enhance investment returns, manage risk, or improve portfolio efficiency.
Ratings & reviews
OTHER SHARE CLASSES OF THIS FUND
